$PODD
INSULET CORP Stock $podd

$podd Overview Financials Valuation SEC Filings Company Website

2019 Q1 Form 10-Q Financial Statement

#000114519719000020 Filed on May 03, 2019

Income Statement

Concept	2019 Q1	2018 Q4	2018 Q1
Revenue	$1.800M	$164.9M	$123.6M
YoY Change	-98.54%	26.34%	21.5%
Cost Of Revenue	$52.90M	$54.60M	$47.76M
YoY Change	10.76%	7.06%	12.87%
Gross Profit	$106.7M	$110.3M	$75.80M
YoY Change	40.77%	38.73%	27.61%
Gross Profit Margin	5927.78%	66.89%	61.34%
Selling, General & Admin	$92.76M	$65.60M	$55.55M
YoY Change	66.99%	6.67%	17.67%
% of Gross Profit	86.94%	59.47%	73.28%
Research & Development	$32.50M	$28.50M	$20.27M
YoY Change	60.36%	51.6%	15.81%
% of Gross Profit	30.46%	25.84%	26.74%
Depreciation & Amortization	$5.100M	$4.400M	$3.522M
YoY Change	44.8%	32.53%	5.99%
% of Gross Profit	4.78%	3.99%	4.65%
Operating Expenses	$99.43M	$94.10M	$75.82M
YoY Change	31.15%	17.19%	17.17%
Operating Profit	$7.300M	$16.23M	$0.00
YoY Change		-2213.67%	-100.0%
Interest Expense	$6.600M	-$5.300M	-$6.200M
YoY Change	-206.45%	-3.64%	34.78%
% of Operating Profit	90.41%	-32.65%
Other Income/Expense, Net	-$2.561M		-$6.236M
YoY Change	-58.93%		36.37%
Pretax Income	$4.700M	$10.90M	-$6.236M
YoY Change	-175.37%	-257.97%	-36.89%
Income Tax	$300.0K	$1.000M	$300.0K
% Of Pretax Income	6.38%	9.17%
Net Earnings	$4.400M	$9.900M	-$6.600M
YoY Change	-166.67%	-244.31%	-33.85%
Net Earnings / Revenue	244.44%	6.0%	-5.34%
Basic Earnings Per Share	$0.07	$0.17	-$0.11
Diluted Earnings Per Share	$0.07	$0.16	-$0.11
COMMON SHARES
Basic Shares Outstanding	59.36M shares	59.08M shares	58.48M shares
Diluted Shares Outstanding	61.15M shares		58.48M shares

Balance Sheet

Concept	2019 Q1	2018 Q4	2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$316.4M	$288.9M	$352.0M
YoY Change	-10.11%	-34.36%	38.58%
Cash & Equivalents	$129.3M	$113.9M	$203.1M
Short-Term Investments	$187.1M	$175.0M	$148.9M
Other Short-Term Assets	$28.00M	$24.30M	$17.40M
YoY Change	60.92%	145.45%	112.2%
Inventory	$73.82M	$71.40M	$33.04M
Prepaid Expenses	$20.12M	$16.98M	$10.60M
Receivables	$68.66M	$63.30M	$50.38M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$496.4M	$461.3M	$547.1M
YoY Change	-9.27%	-14.12%	62.26%
LONG-TERM ASSETS
Property, Plant & Equipment	$299.6M	$258.4M	$153.0M
YoY Change	95.78%	139.56%	134.42%
Goodwill	$39.70M	$39.60M	$39.77M
YoY Change	-0.18%	-0.5%	0.19%
Intangibles		$10.38M
YoY Change		138.63%
Long-Term Investments	$76.80M	$140.8M	$164.1M
YoY Change	-53.2%	12.19%
Other Assets	$3.161M	$2.278M	$15.30M
YoY Change	-79.33%	15.69%	2428.1%
Total Long-Term Assets	$456.2M	$467.4M	$292.9M
YoY Change	55.76%	67.18%	171.73%
TOTAL ASSETS
Total Short-Term Assets	$496.4M	$461.3M	$547.1M
Total Long-Term Assets	$456.2M	$467.4M	$292.9M
Total Assets	$952.6M	$928.7M	$840.0M
YoY Change	13.41%	13.71%	88.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$26.83M	$25.50M	$33.85M
YoY Change	-20.72%	4.45%	427.77%
Accrued Expenses	$85.95M	$90.20M	$45.76M
YoY Change	87.82%	52.22%	43.72%
Deferred Revenue	$1.195M	$1.200M	$4.981M
YoY Change	-76.01%	-49.07%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$3.451M
YoY Change
Total Short-Term Liabilities	$114.0M	$115.7M	$88.65M
YoY Change	28.57%	34.5%	125.12%
LONG-TERM LIABILITIES
Long-Term Debt	$599.6M	$592.0M	$569.9M
YoY Change	5.22%	4.56%	69.22%
Other Long-Term Liabilities	$15.41M	$8.900M	$6.301M
YoY Change	144.53%	47.6%	20.45%
Total Long-Term Liabilities	$615.0M	$600.9M	$576.2M
YoY Change	6.74%	5.02%	68.48%
TOTAL LIABILITIES
Total Short-Term Liabilities	$114.0M	$115.7M	$88.65M
Total Long-Term Liabilities	$615.0M	$600.9M	$576.2M
Total Liabilities	$729.0M	$716.6M	$661.1M
YoY Change	10.26%	8.87%	73.35%
SHAREHOLDERS EQUITY
Retained Earnings	-$679.2M	-$683.6M	-$686.9M
YoY Change	-1.12%	-3.34%	-0.51%
Common Stock	$60.00K	$100.0K	$59.00K
YoY Change	1.69%	72.41%	1.72%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$223.6M	$212.1M	$170.6M
YoY Change
Total Liabilities & Shareholders Equity	$952.6M	$928.7M	$840.0M
YoY Change	13.41%	13.71%	88.78%

Cashflow Statement

Concept	2019 Q1	2018 Q4	2018 Q1
OPERATING ACTIVITIES
Net Income	$4.400M	$9.900M	-$6.600M
YoY Change	-166.67%	-244.31%	-33.85%
Depreciation, Depletion And Amortization	$5.100M	$4.400M	$3.522M
YoY Change	44.8%	32.53%	5.99%
Cash From Operating Activities	$6.500M	$30.44M	-$4.266M
YoY Change	-252.37%	39.63%	-80.46%
INVESTING ACTIVITIES
Capital Expenditures	$44.40M	-$34.79M	$35.37M
YoY Change	25.52%	18.25%	37.75%
Acquisitions
YoY Change
Other Investing Activities	$52.88M	-$5.990M	-$20.61M
YoY Change	-356.57%	-95.0%	24.08%
Cash From Investing Activities	$7.600M	-$40.78M	-$55.99M
YoY Change	-113.57%	-72.69%	32.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	-$8.761M		-$2.261M
YoY Change	287.48%		-135.69%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$1.500M	-1.590M	-$8.870M
YoY Change	-116.91%	-100.53%	-403.04%
NET CHANGE
Cash From Operating Activities	$6.500M	30.44M	-$4.266M
Cash From Investing Activities	$7.600M	-40.78M	-$55.99M
Cash From Financing Activities	$1.500M	-1.590M	-$8.870M
Net Change In Cash	$15.40M	-11.93M	-$69.12M
YoY Change	-122.28%	-107.0%	12.96%
FREE CASH FLOW
Cash From Operating Activities	$6.500M	$30.44M	-$4.266M
Capital Expenditures	$44.40M	-$34.79M	$35.37M
Free Cash Flow	-$37.90M	$65.23M	-$39.64M
YoY Change	-4.39%	27.35%	-16.57%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q1	dei	Amendment Flag AmendmentFlag	false
CY2019Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	59675242	shares
CY2019Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2019Q1	podd	Debt Instrument Stated Coupon Rate Interest Expense DebtInstrumentStatedCouponRateInterestExpense	2462000	USD
CY2019Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2019Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019Q1	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
CY2018Q1	podd	Debt Instrument Stated Coupon Rate Interest Expense DebtInstrumentStatedCouponRateInterestExpense	2480000	USD
CY2019Q1	dei	Document Type DocumentType	10-Q
CY2019Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001145197
CY2018Q1	podd	Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities	-20950000	USD
CY2019Q1	podd	Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities	-5256000	USD
CY2019Q1	dei	Entity Registrant Name EntityRegistrantName	INSULET CORPORATION
CY2019Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2019Q1	dei	Trading Symbol TradingSymbol	PODD
CY2019Q1	podd	Finite Lived Intangible Assets Amortization Expense Thereafter FiniteLivedIntangibleAssetsAmortizationExpenseThereafter	3348000	USD
CY2019Q1	podd	Finited Lived Intangible Assets Excluding Software In Process Of Development Net FinitedLivedIntangibleAssetsExcludingSoftwareInProcessOfDevelopmentNet	11484000	USD
CY2018Q1	podd	Increase Decrease In Accounts Receivable And Unbilled Revenue IncreaseDecreaseInAccountsReceivableAndUnbilledRevenue	-1800000	USD
CY2018Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	88973000	USD
CY2019Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	68655000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	88973000	USD
CY2019Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	85945000	USD
CY2019Q1	podd	Increase Decrease In Accounts Receivable And Unbilled Revenue IncreaseDecreaseInAccountsReceivableAndUnbilledRevenue	2796000	USD
CY2018Q1	podd	Interestand Other Expense Total InterestandOtherExpenseTotal	9643000	USD
CY2018Q1	podd	Interestand Other Expense Total InterestandOtherExpenseTotal	9600000	USD
CY2019Q1	podd	Interestand Other Expense Total InterestandOtherExpenseTotal	10100000	USD
CY2019Q1	podd	Interestand Other Expense Total InterestandOtherExpenseTotal	10085000	USD
CY2019Q1	podd	Lessee Operating Lease Lease Not Yet Commenced Additional Commitments LesseeOperatingLeaseLeaseNotYetCommencedAdditionalCommitments	0	lease
CY2018Q1	podd	Payments To Acquire Property Plant And Equipment From Prior Period Purchase PaymentsToAcquirePropertyPlantAndEquipmentFromPriorPeriodPurchase	4000000	USD
CY2019Q1	podd	Payments To Acquire Property Plant And Equipment From Prior Period Purchase PaymentsToAcquirePropertyPlantAndEquipmentFromPriorPeriodPurchase	11500000	USD
CY2018Q4	podd	Value Added Tax Current ValueAddedTaxCurrent	8463000	USD
CY2019Q1	podd	Value Added Tax Current ValueAddedTaxCurrent	7898000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	25500000	USD
CY2019Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	26833000	USD
CY2018Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	7742000	USD
CY2019Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	7496000	USD
CY2018Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	66904000	USD
CY2019Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	72513000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	63294000	USD
CY2019Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	85945000	USD
CY2018Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	14925000	USD
CY2019Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	15405000	USD
CY2018Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	37822000	USD
CY2019Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	31184000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2905000	USD
CY2019Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3085000	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	898559000	USD
CY2019Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	905891000	USD
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	-12000	USD
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8181000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5784000	USD
CY2018Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8181000	USD
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5784000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3610000	USD
CY2019Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3858000	USD
CY2018Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	6522000	USD
CY2019Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	6943000	USD
CY2018Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	641000	USD
CY2019Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	680000	USD
CY2018Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	7163000	USD
CY2019Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	7623000	USD
CY2018Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	400000	USD
CY2019Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	600000	USD
CY2018Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14712884	shares
CY2019Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10871548	shares
CY2018Q4	us-gaap	Assets Assets	928744000	USD
CY2019Q1	us-gaap	Assets Assets	952612000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	461286000	USD
CY2019Q1	us-gaap	Assets Current AssetsCurrent	496382000	USD
CY2018Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	175040000	USD
CY2019Q1	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	187120000	USD
CY2018Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	17500000	USD
CY2019Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	12700000	USD
CY2019Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	2000000	USD
CY2019Q1	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0	USD
CY2019Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	25100000	USD
CY2018Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	7277000	USD
CY2019Q1	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	7906000	USD
CY2019Q1	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	7900000	USD
CY2018Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	15988000	USD
CY2019Q1	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	17200000	USD
CY2019Q1	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	17211000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	113906000	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	129254000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	272577000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	203146000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	113906000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	129254000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-69431000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	15348000	USD
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2019Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	59188758	shares
CY2019Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	59638439	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	59188758	shares
CY2019Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	59638439	shares
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	59000	USD
CY2019Q1	us-gaap	Common Stock Value CommonStockValue	60000	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7612000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4198000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1184000	USD
CY2019Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1195000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	900000	USD
CY2019Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1000000	USD
CY2018Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2100000	USD
CY2019Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	900000	USD
CY2018Q1	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	0	USD
CY2019Q1	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	0	USD
CY2018Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	47763000	USD
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	52859000	USD
CY2018Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	143616000	USD
CY2019Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	136673000	USD
CY2019Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	74	Security
CY2018Q4	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	18266000	USD
CY2019Q1	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	28658000	USD
CY2018Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	11898000	USD
CY2019Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	11218000	USD
CY2018Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3522000	USD
CY2019Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5135000	USD
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
CY2018Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-307000	USD
CY2019Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-188000	USD
CY2019Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	52470000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	6988000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7641000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2325000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1910000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	846000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1233000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1822000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	17371000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	19125000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10383000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	11484000	USD
CY2018Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	22499000	USD
CY2019Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	25861000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	39646000	USD
CY2019Q1	us-gaap	Goodwill Goodwill	39694000	USD
CY2019Q1	us-gaap	Goodwill Goodwill	39700000	USD
CY2019Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2018Q1	us-gaap	Gross Profit GrossProfit	75815000	USD
CY2019Q1	us-gaap	Gross Profit GrossProfit	106696000	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-6236000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	4704000	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	333000	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	300000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	326000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	300000	USD
CY2018Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-2165000	USD
CY2019Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	11000	USD
CY2018Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-6706000	USD
CY2019Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2690000	USD
CY2018Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	627000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-740000	USD
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3324000	USD
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5563000	USD
CY2018Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1700000	USD
CY2019Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	3500000	USD
CY2018Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	7900000	USD
CY2018Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	7918000	USD
CY2019Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	6600000	USD
CY2019Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	6615000	USD
CY2018Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	30845000	USD
CY2019Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	30654000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	71414000	USD
CY2019Q1	us-gaap	Inventory Net InventoryNet	73822000	USD
CY2018Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	10347000	USD
CY2019Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	12246000	USD
CY2018Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	30222000	USD
CY2019Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	30922000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	11742000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	561000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	269000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2575000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2899000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2954000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	2484000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1548000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P5Y
CY2018Q4	us-gaap	Liabilities Liabilities	716645000	USD
CY2019Q1	us-gaap	Liabilities Liabilities	728982000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	928744000	USD
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	952612000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	115657000	USD
CY2019Q1	us-gaap	Liabilities Current LiabilitiesCurrent	113973000	USD
CY2018Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	591978000	USD
CY2019Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	599601000	USD
CY2018Q4	us-gaap	Long Term Investments LongTermInvestments	140784000	USD
CY2019Q1	us-gaap	Long Term Investments LongTermInvestments	76789000	USD
CY2015Q2	us-gaap	Loss Contingency Claims Dismissed Number LossContingencyClaimsDismissedNumber	2	LegalMatter
CY2015Q2	us-gaap	Loss Contingency New Claims Filed Number LossContingencyNewClaimsFiledNumber	3	LegalMatter
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-8870000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1549000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-55988000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	7620000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4266000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6367000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-6569000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	4378000	USD
CY2018Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-6236000	USD
CY2019Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2561000	USD
CY2019Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2018Q1	us-gaap	Operating Expenses OperatingExpenses	75815000	USD
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	99431000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	0	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	7265000	USD
CY2019Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	900000	USD
CY2019Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	10194000	USD
CY2019Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2315000	USD
CY2019Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7879000	USD
CY2018Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	600000	USD
CY2019Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	800000	USD
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8286000	USD
CY2019Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.067
CY2019Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y11M9D
CY2018Q1	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	800000	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	17320000	USD
CY2019Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	21297000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2278000	USD
CY2019Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3161000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-318000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-815000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1043000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-180000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-725000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	635000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	9010000	USD
CY2019Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15408000	USD
CY2018Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1682000	USD
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4054000	USD
CY2018Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	46000	USD
CY2019Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-326000	USD
CY2018Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	700000	USD
CY2019Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	300000	USD
CY2018Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	11816000	USD
CY2019Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	7512000	USD
CY2018Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	60880000	USD
CY2019Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	2156000	USD
CY2018Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	35374000	USD
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	45255000	USD
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2019Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2019Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	24254000	USD
CY2019Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	28028000	USD
CY2018Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	16977000	USD
CY2019Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	20122000	USD
CY2018Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2961000	USD
CY2019Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	9061000	USD
CY2018Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	40266000	USD
CY2019Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	55031000	USD
CY2017Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	5337000	USD
CY2018Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	5386000	USD
CY2018Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	6379000	USD
CY2019Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	6283000	USD
CY2018Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	2701000	USD
CY2019Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	2665000	USD
CY2018Q4	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	3678000	USD
CY2019Q1	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	3618000	USD
CY2018Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	1923000	USD
CY2019Q1	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	2315000	USD
CY2018Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	1972000	USD
CY2019Q1	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	2219000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	258379000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	299605000	USD
CY2018Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	697000	USD
CY2019Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	807000	USD
CY2018Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	15000	USD
CY2019Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
CY2018Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20267000	USD
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	31954000	USD
CY2018Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2700000	USD
CY2019Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2700000	USD
CY2018Q1	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-11815000	USD
CY2019Q1	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-7512000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-683614000	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-679236000	USD
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	123578000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	159555000	USD
CY2018Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	2100000	USD
CY2019Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	2200000	USD
CY2019Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	8300000	USD
CY2018Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	33049000	USD
CY2019Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	41616000	USD
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	8181000	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	5784000	USD
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2191005	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	36.21
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	15810000	USD
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	35965	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	114040	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	153897000	USD
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3077624	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2882617	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	39.16
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	41.71
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	149128000	USD
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2743607	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	34.45
CY2019Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	38.32
CY2019Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	92.16
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	129008000	USD
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y6M26D
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y5M16D
CY2019Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	273082	shares
CY2018Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2961000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	9061000	USD
CY2018Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	8243	shares
CY2019Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	3609	shares
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	158516000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	170568000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	212099000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	223630000	USD
CY2018Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	13378000	USD
CY2019Q1	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	9503000	USD
CY2019Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2018Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	58482786	shares
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61148428	shares
CY2018Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	58482786	shares
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59355031	shares
CY2019Q1	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nature of the Business </font></div><div style="line-height:120%;padding-top:0px;text-align:left;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:0px;text-align:left;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Insulet Corporation (the "Company") is primarily engaged in the development, manufacturing and sale of its proprietary Omnipod® System, an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of two product lines: the Omnipod Insulin Management System (“Omnipod”), which the Company has been selling since 2005, and its next generation Omnipod DASH</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">TM</sup></font><font style="font-family:inherit;font-size:10pt;"> Insulin Management System ("Omnipod DASH" or "DASH"), which began a U.S. limited market release in 2018. Collectively, we refer to these products as the "Omnipod System".</font></div><div style="line-height:120%;padding-top:0px;text-align:left;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:0px;text-align:left;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition to using the Omnipod System for insulin delivery, the Company also partners with global pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of their drugs across other therapeutic areas. The majority of the Company's drug delivery revenue currently consists of sales to Amgen supplying the Neulasta Onpro kit, an innovative delivery system for Amgen’s white blood cell booster to help reduce the risk of infection during intense chemotherapy.</font></div></div>
CY2019Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:0px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Reclassification of Prior Period Amounts</font></div><div style="line-height:120%;padding-top:0px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain reclassifications have been made to prior period amounts to conform to the current period financial statement presentation. Software license costs have been reallocated from general and administrative expenses to research and development and sales and marketing expenses based on license usage.</font></div></div>
CY2019Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates in Preparation of Financial Statements</font></div><div style="line-height:120%;padding-top:0px;text-indent:0px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions in the application of certain of its significant accounting policies that may materially affect the reported amounts of assets, liabilities, equity, revenue and expenses. Actual results may differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001145197-19-000020-index-headers.html	Edgar Link	pending
0001145197-19-000020-index.html	Edgar Link	pending
0001145197-19-000020.txt	Edgar Link	pending
0001145197-19-000020-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
podd-20190331.xml	Edgar Link	completed
podd-20190331.xsd	Edgar Link	pending
podd-20190331_cal.xml	Edgar Link	unprocessable
podd-20190331_def.xml	Edgar Link	unprocessable
podd-20190331_lab.xml	Edgar Link	unprocessable
podd-20190331_pre.xml	Edgar Link	unprocessable
podd-2019x03x31_10q.htm	Edgar Link	pending
podd-exx102_20190331x10q.htm	Edgar Link	pending
podd-exx311_20190331x10q.htm	Edgar Link	pending
podd-exx312_20190331x10q.htm	Edgar Link	pending
podd-exx321_20190331x10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PODD
INSULET CORP Stock $podd

2019 Q1 Form 10-Q Financial Statement

#000114519719000020 Filed on May 03, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PODD INSULET CORP Stock $podd

2019 Q1 Form 10-Q Financial Statement

#000114519719000020 Filed on May 03, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PODD
INSULET CORP Stock $podd